Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $44M | $19M | $12M | $2M | 729.6% | 35.0% | -135.7% |
| 2024 | $33M | $-18M | $-33M | $2M | 209.5% | 60.0% | 28.2% |
| 2023 | $20M | $-9M | $-26M | $-5M | 59.8% | 21.8% | 150.7% |
| 2022 | $17M | $5M | $-10M | $-17M | 25.1% | - | - |
| 2021 | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 44.05 |
| Operating Revenue | 44.05 |
| Cost Of Revenue | 10.08 |
| Gross Profit | 33.97 |
| Operating Expense | 29.02 |
| Research And Development | 1.35 |
| Selling General And Administration | 26.79 |
| Total Expenses | 39.11 |
| Operating Income | 4.94 |
| Total Operating Income As Reported | 4.94 |
| EBITDA | 19.43 |
| Normalized EBITDA | 11.99 |
| EBIT | 18.14 |
| Interest Expense | 6.25 |
| Net Interest Income | -6.25 |
| Other Non Operating Income Expenses | 5.77 |
| Other Income Expense | 13.20 |
| Interest Expense Non Operating | 6.25 |
| Net Non Operating Interest Income Expense | -6.25 |
| Pretax Income | 11.90 |
| Tax Provision | 0.09 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | 0.05 |
| Net Income Continuous Operations | 11.81 |
| Net Income From Continuing And Discontinued Operation | 11.81 |
| Net Income From Continuing Operation Net Minority Interest | 11.81 |
| Net Income | 11.81 |
| Net Income Common Stockholders | 11.81 |
| Net Income Including Noncontrolling Interests | 11.81 |
| Normalized Income | 4.43 |
| Diluted NI Availto Com Stockholders | 11.81 |
| Basic Average Shares | 8.56 |
| Diluted Average Shares | 9.08 |
| Reconciled Depreciation | 1.28 |
| Reconciled Cost Of Revenue | 9.68 |
| Total Unusual Items | 7.43 |
| Total Unusual Items Excluding Goodwill | 7.43 |
| Special Income Charges | -0.67 |
| Other Special Charges | 0.48 |
| Impairment Of Capital Assets | 0.20 |
| Gain On Sale Of Security | 8.11 |
| Depreciation Amortization Depletion Income Statement | 0.88 |
| Depreciation And Amortization In Income Statement | 0.88 |
| General And Administrative Expense | 19.37 |
| Other Gand A | 19.37 |
| Total Other Finance Cost | - |
| Selling And Marketing Expense | 7.42 |
| Depreciation Income Statement | 0.88 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| SANUWAVE Health, Inc.this co. | SNWV | $132M | 11.20 | 81.74 | 729.6% | 7.38 |
| CVRx, Inc. | CVRX | $156M | - | 3.97 | -135.6% | - |
| Nano-X Imaging Ltd. | NNOX | $144M | -1.92 | 1.03 | -53.7% | -2.10 |
| Health Catalyst, Inc. | HCAT | $143M | -0.81 | 0.58 | -72.4% | -2.57 |
| TuHURA Biosciences, Inc. | HURA | $139M | -4.64 |
| - |
| - |
| - |
| - |
| - |
| 6.75 |
| -145.5% |
| -4.65 |
| AVITA Medical, Inc. | RCEL | $134M | -2.76 | -8.06 | 291.8% | -4.12 |
| MaxCyte, Inc. | MXCT | $132M | -2.95 | 0.77 | -26.0% | -3.23 |
| The Joint Corp. | JYNT | $117M | 40.32 | 7.80 | 19.3% | 118.19 |
| Aldeyra Therapeutics, Inc. | ALDX | $106M | -3.14 | 2.40 | -76.5% | -1.63 |
| Peer Median | - | -2.76 | 1.72 | -63.0% | -2.57 | |